Urology News and Research

Latest Urology News and Research

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Taiho Oncology, Inc., a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today detailed findings from its global Phase III RECOURSE trial of TAS-102 (nonproprietary names: trifluridine and tipiracil hydrochloride), an oral combination anticancer drug.

28 Jun 2014

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring's human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development.

24 Jun 2014

OAB and interstitial cystitis/bladder pain syndrome show considerable overlap

There is considerable overlap between symptoms in patients with interstitial cystitis/bladder pain syndrome and those with overactive bladder, US researchers have shown.

23 Jun 2014

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

Laborie Medical Technologies, Inc., based in Toronto, Ontario, has completed its acquisition of BUCK Elektromedizin GmbH and BUCKmeditec GmbH & Co. Bad Rappenaeau, Germany based BUCK develops and distributes innovative and advanced biofeedback and electrical stimulation equipment, accessories and consumables for pelvic floor dysfunction in the treatment of urinary and fecal incontinence.

18 Jun 2014

Children's Hospital Los Angeles ranked among nation's top 5 again

For the third straight year, Children's Hospital Los Angeles is ranked among the top five children's hospitals in the country, a distinction that recognizes the hospital's clinical expertise and the quality and breadth of its patient care.

11 Jun 2014

African-American women at increased risk for deadlier breast cancers, study finds

A research study led by cancer specialists at MedStar Washington Hospital Center found that African-American women frequently present with biologically less favorable subtypes of breast cancer.

10 Jun 2014

Urodynamic study clinically useful in young men with LUTS

Urodynamic studies are useful for aiding diagnosis and treatment decisions in young men with chronic lower urinary tract symptoms but without symptoms suggestive of chronic prostatitis, Korean researchers say.

9 Jun 2014

Researchers recommend iron supplementation to women with heavy menstrual bleeding

A study by researchers from Finland found that diagnosis and treatment of anemia is important to improve quality of life among women with heavy periods.

9 Jun 2014

Prostate biopsy method impacts cancer risk profile

Prostate cancers that are classified as “low risk” based on conventional prostate biopsy and histology are frequently found to be higher risk when assessed using the newer targeted biopsy method, US researchers have warned.

5 Jun 2014

SYNERA can help prevent needle stick pain associated with superficial IVs

Galen US Incorporated today announced that the U.S. Food and Drug Administration (FDA) recently approved a labeling change that allows SYNERA® (lidocaine and tetracaine) topical patch to be used at home.

4 Jun 2014

Squatty Potty toilet stool improves severity of constipation symptoms

When used as a treatment, the original Squatty Potty (www.squattypotty.com) toilet stool significantly improves the severity of constipation symptoms within one month of use among 84 percent of the participants of a recently released scientific study.

4 Jun 2014

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Polyarticular Juvenile Idiopathic Arthritis (PJIA) is a type of Juvenile Idiopathic Arthritis (JIA), a group of Rheumatoid Arthritis (RA) diseases that manifests in multiple ways in children.

3 Jun 2014

New investigational immunotherapy benefits people with advanced urothelial bladder cancer

A new investigational immunotherapy MPDL3280A has been shown to shrink tumours in 43% of people (13/30) who had previously been treated for advanced urothelial bladder cancer (UBC) with a specific type of tumour (PD-L1 positive).

3 Jun 2014

EHR solutions provider, ChartLogic, partners with Kareo

ChartLogic, a leader in electronic health record solutions for specialty and primary care physician practices, today announced a partnership with billing solutions powerhouse, Kareo, that will allow the company to offer its clients best-of-breed revenue cycle management.

2 Jun 2014

ProMark test for prostate cancer meets primary endpoint

Today, for the first time, Metamark presents results from the clinical validation study that showed ProMark, the first and only proteomic-based imaging biopsy test, achieved its primary endpoint by accurately differentiating between aggressive and non-aggressive forms of prostate cancer at early stages of disease.

2 Jun 2014

Urology News and Research

Latest Urology News and Research

Taiho Oncology presents TAS-102 Phase III RECOURSE trial results in mCRC patients

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

OAB and interstitial cystitis/bladder pain syndrome show considerable overlap

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

Children's Hospital Los Angeles ranked among nation's top 5 again

African-American women at increased risk for deadlier breast cancers, study finds

Urodynamic study clinically useful in young men with LUTS

Researchers recommend iron supplementation to women with heavy menstrual bleeding

Prostate biopsy method impacts cancer risk profile

SYNERA can help prevent needle stick pain associated with superficial IVs

Squatty Potty toilet stool improves severity of constipation symptoms

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

New investigational immunotherapy benefits people with advanced urothelial bladder cancer

EHR solutions provider, ChartLogic, partners with Kareo

ProMark test for prostate cancer meets primary endpoint

Scientists define genetic cause for two types of birth defects in newborn boys

Investigational drug for advanced bladder cancer shows promise for treatment of certain tumor types

Actavis signs deal with Cephalon to settle patent litigation related to Nuvigil tablets

Men who receive radiation therapy for prostate cancer more likely to develop rectal cancer

Initial biopsy with epigenetic test rules out prostate cancer up to 88%

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in